Reuters Health Report

Click to View in Browser 01/30/2014 Israel's Oramed a step closer in race for first insulin pill JERUSALEM (Reuters) - Israel's Oramed, which is racing Novo Nordisk of Denmark to develop the world's first insulin pill, moved a step closer to its goal on Thursday by announcing successful results from a small mid-stage test. Many chronically ill Americans unable to afford food, medicine NEW YORK (Reuters Health) - One in three Americans with a chronic disease such as diabetes, arthritis or high blood pressure has difficulty paying for food, medications or both, according to a new study. Aveo Oncology to end breast cancer study due to low enrollment (Reuters) - Aveo Oncology said it would end a mid-stage trial testing its lead drug as a treatment for breast cancer, as the company did not have enough patients enrolled in the study. Denmark's Novo Nordisk sees copycat drugs hitting sales COPENHAGEN (Reuters) - Novo Nordisk, the world's largest insulin producer, raised its 2014 outlook by less than investors had hoped for saying it expected sales to be hit by contract losses in the United States and competition from cheaper generic drugs. New British biotech firm to tap gene therapy for blindness LONDON (Reuters) - Oxford scientists have set up a biotechnology company to develop the use of gene therapy in treating blindness, and the Wellcome Trust medical charity has invested 12 million pounds ($20 million) in the start-up. J&J chooses Yale to review requests for clinical drug data (Reuters) - Johnson & Johnson has selected the Yale School of Medicine to review requests from investigators and physicians looking for access to clinical trial data involving the diversified healthcare company's pharmaceuticals. Scientists hail breakthrough in embryonic-like stem cells LONDON (Reuters) - In experiments that could open a new era in stem cell biology, scientists have found a simple way to reprogram mature animal cells back into an embryonic-like state that allows them to generate many types of tissue. Roche profits rise, payout level prompts M&A questions BASEL (Reuters) - Roche offered shareholders a lower-than-expected dividend payout after reporting an 18 percent rise in full-year net profit, potentially a sign the Swiss pharmaceuticals group might be keeping its cash for deals. Being overweight in kindergarten sets stage for later obesity NEW YORK (Reuters Health) - Children who are overweight when they start school are far more likely to be obese by the time they become teenagers, according to a new study of nearly 8,000 children. KaloBios Pharma pulls plug on asthma drug, shares plunge (Reuters) - Shares of KaloBios Pharmaceuticals Inc fell nearly 50 percent in extended trade after the company said it would stop developing an asthma drug that failed in a mid-stage study. Related Video Birds' V-formation mystery solved Rare snow storm hits southern U.S. The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today   A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today   » MORE NEWSLETTERS

- 3 Times Square New York, NY 10036 USA © Copyright 2010 Thomson Reuters Ensure delivery of Reuters Newsmails, add mail@nl.reuters.com to your address book. Details Subscribe to other Reuters newsletters. Unsubscribe from this newsletter. Follow us on Twitter Friend us on Facebook Forward to a friend